15.37 USD
↗ 0.22 (1.48%)PRE MARKET (AS OF 05:03 AM EDT)
Q32 Bio Inc. Common Stock
QTTBNASDAQ • USD
Market: OPEN
Shares of Q32 Bio Inc. Common Stock (QTTB) are trading at $15.37. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (71.8%), a bullish Golden Cross on the moving averages and bullish moving average alignment. QTTB is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 24, 2026.
Open?$15.10
High?$15.37
Low?$15.10
Prev. Close?$15.15
Volume?357
Avg. Volume?1.9M
VWAP?$15.25
Rel. Volume?0.00x
Bid / Ask
Bid?$12.47 × 100
Ask?$18.22 × 100
Spread?$5.75
Midpoint?$15.34
Valuation & Ratios
Market Cap?450.1M
Shares Out?29.8M
Float?5.6M
Float %?38.0%
P/E Ratio?13.54
P/B Ratio?9.72
EPS?$1.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Address
830 WINTER STREET
WALTHAM, MA 02451
Phone: 781-999-0232
WALTHAM, MA 02451
Phone: 781-999-0232
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?77
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?13.71Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?40.76%Squeeze Risk
Short Interest?2.3M
Days to Cover?1.0
Free Float5.6M
Avg Daily Volume4.1M
Settlement Date2026-07-15
Financial Health
Current Ratio?5.36Strong
Quick Ratio?5.36Strong
Cash Ratio?4.76Strong
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score53/100
P/E?13.5CHEAP▾
Peers100
S&P86
P/B?9.72HIGH▾
Peers100
S&P19
P/S?8.38HIGH▾
Peers100
S&P12
P/FCF?N/A▾
EV/EBITDA?18.7FAIR▾
Peers100
S&P31
EV/Sales?7.58HIGH▾
Peers100
S&P18
Returns & Efficiency
ROE?71.8%STRONG▾
Peers50
S&P94
ROA?52.2%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$407.5M
Fundamentals ratios updated end of day